Fund Holdings — Rock Springs Capital Management LP

Total Portfolio Value:
$3.31B
Total Bought:
$431.61M
Total Sold:
$800.83M
Net Transaction:
-$369.22M
Notable People:
Rock Springs Capital Llc
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Blueprint Medicines Corp2,498,4482,460,417-38,031$237.00M$265.18M8.00%+$28.18M
UnitedHealth Group Incorporated(UNH)230,000275,000+45,000$113.78M$140.05M4.23%+$26.27M
Intuitive Surgical, Inc.(ISRG)298,500298,5000$119.13M$132.79M4.01%+$13.66M
Neurocrine Biosciences, Inc.(NBIX)1,054,900940,000-114,900$145.49M$129.41M3.91%-$16.08M
Eli Lilly and Company(LLY)103,250121,500+18,250$80.32M$110.00M3.32%+$29.68M
argenx SEADR(ARGX)229,250229,2500$90.26M$98.59M2.98%+$8.33M
Acadia Healthcare Company, Inc.(ACHC)1,177,5001,177,5000$93.28M$79.53M2.40%-$13.75M
Ultragenyx Pharmaceutical Inc.(RARE)1,774,9381,924,072+149,134$82.87M$79.08M2.39%-$3.79M
Evolent Health, Inc.CL A(EVH)3,987,5004,077,500+90,000$130.75M$77.96M2.35%-$52.79M
Madrigal Pharmaceuticals, Inc.(MDGL)285,931245,499-40,432$76.36M$68.78M2.08%-$7.58M
Boston Scientific Corporation(BSX)1,232,500817,500-415,000$84.41M$62.96M1.90%-$21.46M
Freshpet, Inc.(FRPT)662,500480,000-182,500$76.76M$62.11M1.87%-$14.65M
Alnylam Pharmaceuticals, Inc.(ALNY)244,000250,000+6,000$36.47M$60.75M1.83%+$24.28M
Mirum Pharmaceuticals, Inc.(MIRM)1,856,5641,772,038-84,526$46.64M$60.59M1.83%+$13.95M
Merus N V1,146,5601,001,073-145,487$51.63M$59.23M1.79%+$7.60M
IDEXX Laboratories, Inc.(IDXX)179,250119,500-59,750$96.78M$58.22M1.76%-$38.56M
agilon health, inc.(AGL)8,835,0008,900,000+65,000$53.89M$58.21M1.76%+$4.31M
DexCom, Inc.(DXCM)596,750500,000-96,750$82.77M$56.69M1.71%-$26.08M
Humana Inc.(HUM)147,408147,4080$51.11M$55.08M1.66%+$3.97M
Insmed Incorporated(INSM)0808,356+808,356$0$54.16M1.63%+$54.16M
Rhythm Pharmaceuticals, Inc.(RYTM)1,522,8931,280,493-242,400$65.99M$52.58M1.59%-$13.41M
Celldex Therapeutics, Inc.(CLDX)1,372,1851,398,994+26,809$57.59M$51.78M1.56%-$5.81M
Phreesia, Inc.(PHR)2,365,0002,417,500+52,500$56.59M$51.25M1.55%-$5.34M
Edwards Lifesciences Corp647,300550,000-97,300$61.86M$50.80M1.53%-$11.05M
Xenon Pharmaceuticals Inc.(XENE)1,255,5771,272,877+17,300$54.05M$49.63M1.50%-$4.42M
West Pharmaceutical Services, Inc.(WST)137,250145,500+8,250$54.31M$47.93M1.45%-$6.38M
Penumbra, Inc.(PEN)505,000265,000-240,000$112.71M$47.69M1.44%-$65.01M
Endeavour Silver Corp.(EXK)1,059,7501,081,500+21,750$73.19M$45.69M1.38%-$27.49M
Agios Pharmaceuticals, Inc.(AGIO)1,764,5051,044,261-720,244$51.59M$45.03M1.36%-$6.57M
Sarepta Therapeutics, Inc.(SRPT)327,600284,000-43,600$42.41M$44.87M1.35%+$2.46M
iRhythm Holdings, Inc.(IRTC)392,250397,500+5,250$45.50M$42.79M1.29%-$2.71M
Ascendis Pharma A/SADR(ASND)290,000290,0000$43.84M$39.55M1.19%-$4.29M
Insulet Corporation(PODD)320,000195,000-125,000$54.85M$39.35M1.19%-$15.50M
Structure Therapeutics IncADS412,649999,862+587,213$17.69M$39.26M1.18%+$21.58M
Travere Therapeutics, Inc.(TVTX)3,424,8184,482,265+1,057,447$26.41M$36.84M1.11%+$10.44M
Azenta, Inc.(AZTA)694,750696,000+1,250$41.88M$36.62M1.11%-$5.26M
Revolution Medicines, Inc.(RVMD)923,681943,195+19,514$29.77M$36.61M1.10%+$6.84M
Kymera Therapeutics, Inc.(KYMR)1,522,2381,163,973-358,265$61.19M$34.74M1.05%-$26.45M
Mereo BioPharma Group plcADS(MREO)8,142,1099,283,492+1,141,383$26.87M$33.42M1.01%+$6.55M
Warby Parker Inc.CL A(WRBY)2,080,0002,080,0000$28.31M$33.40M1.01%+$5.10M
Immunovant, Inc.(IMVT)1,150,1231,185,654+35,531$37.16M$31.30M0.94%-$5.86M
Align Technology Inc220,000127,500-92,500$72.14M$30.78M0.93%-$41.36M
Akero Therapeutics Inc1,299,8881,074,261-225,627$32.84M$25.20M0.76%-$7.63M
Johnson & Johnson(JNJ)0170,000+170,000$0$24.85M0.75%+$24.85M
LifeStance Health Group, Inc.(LFST)4,780,0004,827,700+47,700$29.49M$23.70M0.72%-$5.79M
Zai Lab LimitedADR(ZLAB)1,297,1231,297,873+750$20.78M$22.49M0.68%+$1.71M
Pacira BioSciences, Inc.(PCRX)1,055,500785,000-270,500$30.84M$22.46M0.68%-$8.38M
Legend Biotech CorporationADS(LEGN)499,486505,786+6,300$28.02M$22.40M0.68%-$5.61M
BioCryst Pharmaceuticals, Inc.(BCRX)3,496,2563,619,258+123,002$17.76M$22.37M0.67%+$4.61M
Novo Nordisk A/SADR(NVO)147,500147,5000$18.94M$21.05M0.64%+$2.12M
Oscar Health, Inc.CL A(OSCR)2,110,0001,251,500-858,500$31.38M$19.80M0.60%-$11.58M
Nuvalent Inc125,302255,989+130,687$9.41M$19.42M0.59%+$10.01M
Krystal Biotech, Inc.(KRYS)103,969105,569+1,600$18.50M$19.39M0.59%+$887.5K
Inspire Medical Systems, Inc.(INSP)130,500130,000-500$28.03M$17.40M0.53%-$10.63M
Inozyme Pharma Inc3,681,1743,698,374+17,200$28.20M$16.49M0.50%-$11.70M
Dyne Therapeutics, Inc.(DYN)451,824461,028+9,204$12.83M$16.27M0.49%+$3.44M
Dynavax Technologies Corp1,675,4741,292,637-382,837$20.79M$14.52M0.44%-$6.28M
Pharvaris N V
COM
752,924756,931+4,007$17.40M$14.23M0.43%-$3.17M
Immunocore Holdings plcADS(IMCR)2,367,816419,030-1,948,786$153.91M$14.20M0.43%-$139.71M
Vera Therapeutics, Inc.CL A(VERA)341,168381,192+40,024$14.71M$13.79M0.42%-$919.6K
Crinetics Pharmaceuticals In289,400289,4000$13.55M$12.96M0.39%-$584.6K
Prothena Corp PlcSHS
SHS
625,048625,0480$15.48M$12.90M0.39%-$2.58M
Olink Hldg AbADS1,676,500500,000-1,176,500$39.41M$12.74M0.38%-$26.67M
Charles River Laboratories International, Inc.(CRL)48,50060,250+11,750$13.14M$12.45M0.38%-$694.6K
BioMarin Pharmaceutical Inc.(BMRN)148,832151,000+2,168$13.00M$12.43M0.38%-$567.2K
Amicus Therapeutics Inc
COM
1,152,6561,218,580+65,924$13.58M$12.09M0.36%-$1.49M
Nevro Corp1,065,0001,381,500+316,500$15.38M$11.63M0.35%-$3.75M
Cullinan Therapeutics, Inc.(CGEM)0658,338+658,338$0$11.48M0.35%+$11.48M
Enliven Therapeutics Inc428,571428,5710$7.54M$10.02M0.30%+$2.48M
Jasper Therapeutics, Inc.(JSPR)404,335404,3350$11.87M$9.18M0.28%-$2.69M
Novavax, Inc.(NVAX)537,625675,000+137,375$2.57M$8.55M0.26%+$5.98M
Accolade Inc3,540,0002,290,000-1,250,000$37.10M$8.20M0.25%-$28.90M
EDAP TMS S.A.ADR(FOCL)1,475,0001,475,0000$10.84M$8.02M0.24%-$2.82M
Springworks Therapeutics Inc0199,855+199,855$0$7.53M0.23%+$7.53M
Neumora Therapeutics, Inc.(NMRA)646,118760,007+113,889$8.88M$7.47M0.23%-$1.41M
Applied Therapeutics Inc1,497,9181,555,004+57,086$10.19M$7.26M0.22%-$2.92M
Aurinia Pharmaceuticals Inc.(AUPH)1,150,3471,179,740+29,393$5.76M$6.74M0.20%+$973.1K
Mersana Therapeutics Inc3,046,7823,046,7820$13.65M$6.12M0.18%-$7.53M
Beam Therapeutics Inc.(BEAM)147,510249,923+102,413$4.87M$5.86M0.18%+$982.0K
Acumen Pharmaceuticals, Inc.(ABOS)2,300,0592,300,0590$9.32M$5.57M0.17%-$3.75M
Compass Therapeutics, Inc.(CMPX)5,513,7885,513,7880$10.92M$5.51M0.17%-$5.40M
Apellis Pharmaceuticals Inc
COM
0140,700+140,700$0$5.40M0.16%+$5.40M
Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS)000$3.84M$4.74M0.14%+$891.3K
Fulcrum Therapeutics, Inc.(FULC)727,673727,6730$6.87M$4.51M0.14%-$2.36M
MacroGenics, Inc.(MGNX)1,305,2501,053,647-251,603$19.21M$4.48M0.14%-$14.74M
Mineralys Therapeutics, Inc.(MLYS)792,615378,932-413,683$10.23M$4.43M0.13%-$5.80M
Biohaven Ltd.(BHVN)126,984127,558+574$6.94M$4.43M0.13%-$2.52M
Pliant Therapeutics, Inc.(PLRX)384,996384,9960$5.74M$4.14M0.12%-$1.60M
Pulmonx Corporation(LUNG)652,400652,4000$6.05M$4.14M0.12%-$1.91M
Perspective Therapeutics, Inc.(CATX)0401,196+401,196$0$4.00M0.12%+$4.00M
Autolus Therapeutics plcADS(AUTL)1,032,9881,032,9880$6.59M$3.59M0.11%-$3.00M
Essa Pharma Inc677,005677,0050$5.75M$3.56M0.11%-$2.19M
Aclaris Therapeutics, Inc.(ACRS)2,753,4952,753,4950$3.41M$3.03M0.09%-$385.5K
Gossamer Bio, Inc.(GOSS)3,266,9603,266,9600$3.86M$2.94M0.09%-$911.8K
Travere Therapeutics IncNOTE 2 500 9 1000$2.84M$2.89M0.09%+$46.1K
Xilio Therapeutics, Inc.(XLO)1,440,7593,003,259+1,562,500$1.56M$2.85M0.09%+$1.29M
Sagimet Biosciences Inc.COM SER A(SGMT)770,671787,808+17,137$4.18M$2.69M0.08%-$1.48M
Cypherpunk Technologies Inc.(CYPH)911,9371,266,546+354,609$2.43M$2.48M0.07%+$56.7K
Adaptimmune Therapeutics plcADR(ADAPY)2,425,4682,425,4680$3.83M$2.36M0.07%-$1.47M
Vigil Neuroscience Inc471,958471,9580$1.61M$1.89M0.06%+$278.5K
Page 1 of 2
Rock Springs Capital Management LP — 13F Holdings — Q2 2024 | TickerTrail